Regulatory Expertise Leverage QNova LifeSciences’ track record of navigating medical device and drug regulations across 100+ countries and extensive submission success rates to position as the go-to partner for complex global approvals, enabling faster market access for clients with high regulatory risk.

Speed to Market Highlight proven reductions in time to approval and development cycle, with claims of expediting pathways by hundreds of days, to attract clients aiming to shorten time-to-market for new drugs, biologics, and devices.

Diverse Success Emphasize breadth of commercialization outcomes including NDA/ANDA/BLA submissions, 60+ EMA CHMP authorizations, and successful 510(k) filings, appealing to sponsors seeking a single CRO with end-to-end commercialization capabilities.

Orphan and Firsts Target niche sponsors pursuing orphan, first-in-class, or first-in-indication opportunities by showcasing QNova’s specialized track record and feasibility design tools that improve study efficiency and reduce protocol amendments.

Scale-Ready Capabilities Position as a strong partner for mid-sized to large pipelines seeking robust CRO support in medical devices and combination products, leveraging the company’s experience, global reach, and scalable processes to handle increasing submission volume and regulatory complexity.